Infectious mononucleosis and megaloblastic anaemia associated with daraprim and bactrim.
D000293:Adolescent; D000748:Anemia, Macrocytic / Q000209:etiology*; D000749:Anemia, Megaloblastic / Q000188:drug therapy / Q000209:etiology*; D004338:Drug Combinations; D005260:Female; D005494:Folic Acid Deficiency / Q000150:complications* / Q000188:drug therapy; D006470:Hemorrhage; D006801:Humans; D007244:Infectious Mononucleosis / Q000209:etiology*; D011739:Pyrimethamine / Q000009:adverse effects*; D013420:Sulfamethoxazole / Q000009:adverse effects*; D014295:Trimethoprim / Q000009:adverse effects*; D014805:Vitamin B 12 / Q000627:therapeutic use
D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole; D014805:Vitamin B 12; D011739:Pyrimethamine